1-2 of 2
Entezam A. Sahovic, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Report of Safety and Efficacy From a Novel Conditioning Regimen, Individualized Once-Daily Intravenous Busulfan with Bortezomib, in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation.

Edward A. Stadtmauer, MD, Voravit Ratanatharathorn, MD, Rosa F. Yeh, PharmD, Cesar O. Freytes, MD, Juan J. Toro, MD, MSci, Gorgun Akpek, MD, MHS, Entezam A. Sahovic, MD, Guido J. Tricot, MD, PhD, Paul J. Shaughnessy, MD, Darrell J. White, MD, Tulio E. Rodriguez, MD, Scott R. Solomon, MD, Louie H. Yu, BS, Shiva Patil, PhD, Yiping Sun, PhD, Elizabeth Armstrong, MS, Angela Smith, MS, PA, Agnes Elekes, MD, Kazunobu Kato, MD, PhD, Donna Reece
Journal: Blood
Blood (2012) 120 (21): 3080.
https://doi.org/10.1182/blood.V120.21.3080.3080
Published: 2012
Journal Articles

5′-ABL Gene Deletion on Derivative Chromosome 9 Detected by FISH: Prognostic Significance in CML Patients after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Naeem A. Chaudhri, MD, Mahmoud D. Aljurf, MD, Entezam A. Sahovic, MD, Fahad Almhareb, MD, Fahad Al-Sharif, MD, Hazzaa Al-Zahrani, MD, Hamad Al-Omar, MD, Ali Al-Shanqeeti, MD, Syed Zaidi, MD, Manzur Morshed, MD, Khalid Al-Anazi, MD, Ibrahim El-Hassan, Mohammad Al-Lahham, Mohammad A. Iqbal, PhD
Journal: Blood
Blood (2005) 106 (11): 2039.
https://doi.org/10.1182/blood.V106.11.2039.2039
Published: 2005